Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch-Anal Anastomosis for Ulcerative Colitis

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2017 Jan 23

PMID 28110377

Citations 9

Authors

Eleonora Scaioli

Alessandro Sartini

Elisa Liverani

Richard John Digby

Giampaolo Ugolini

Giancarlo Rosati

Gilberto Poggioli

Davide Festi

Franco Bazzoli

Andrea Belluzzi

Affiliations

Soon will be listed here.

Abstract

Background: Pouchitis is the most frequent complication after ileal pouch-anal anastomosis for refractory ulcerative colitis. A non-standardized preventative treatment exists. Sulfasalazine has proved effective in acute pouchitis therapy.

Aims: The aim of this study was to retrospectively evaluate the effect of sulfasalazine in primary prophylaxis of pouchitis after proctocolectomy with ileal pouch-anal anastomosis.

Methods: Data files of patients who underwent total proctocolectomy with ileal pouch-anal anastomosis for refractory ulcerative colitis and/or dysplasia from January 2007 to December 2014, with a follow-up until August 2015, were analyzed. After closure of loop ileostomy, on a voluntary basis, patients received a primary prophylaxis of pouchitis with sulfasalazine (2000 mg per day) continually until acute pouchitis flare and/or drop out due to side effects.

Results: Follow-up data were available for 51 of the 55 surgical patients. Median follow-up time was 68 months (range 10-104). Thirty postoperative complications occurred in 25 patients. 45% of patients developed pouchitis. Sulfasalazine prophylaxis was administered in 39.2% of patients; 15% of the these developed pouchitis versus 64.5% (20/31) of the non-sulfasalazine patients (p < 0.001). Pouchitis-free survival curves were 90.55 months in sulfasalazine patients and 44.46 in non-sulfasalazine patients (log-rank test p = 0.001, Breslow p = 0.001).

Conclusion: Sulfasalazine may be potentially administered in pouchitis prophylaxis after proctocolectomy with ileal pouch-anal anastomosis, but large prospectively controlled trials are needed.

Citing Articles

Key Focus Areas in Pouchitis Therapeutic Status: A Narrative Review.

Hosseini-Asl S, Mehrabani G, Masoumi S Iran J Med Sci. 2024; 49(8):472-486.

PMID: 39205822 PMC: 11347594. DOI: 10.30476/ijms.2024.100782.3326.

Pouchitis: pathophysiology and management.

Shen B Nat Rev Gastroenterol Hepatol. 2024; 21(7):463-476.

PMID: 38664536 DOI: 10.1038/s41575-024-00920-5.

Medical treatment of pouchitis: a guide for the clinician.

Rabbenou W, Chang S Therap Adv Gastroenterol. 2021; 14:17562848211023376.

PMID: 34249146 PMC: 8239975. DOI: 10.1177/17562848211023376.

Chronic Antibiotic-Refractory Pouchitis: Management Challenges.

Outtier A, Ferrante M Clin Exp Gastroenterol. 2021; 14:277-290.

PMID: 34163205 PMC: 8213947. DOI: 10.2147/CEG.S219556.

Pouchitis: Treatment dilemmas at different stages of the disease.

Barreiro-de Acosta M, Baston-Rey I, Calvino-Suarez C, Dominguez-Munoz J United European Gastroenterol J. 2020; 8(3):256-262.

PMID: 32213019 PMC: 7184652. DOI: 10.1177/2050640619900571.

References

Allison J, Herrinton L, Liu L, Yu J, Lowder J . Natural history of severe ulcerative colitis in a community-based health plan. Clin Gastroenterol Hepatol. 2008; 6(9):999-1003. DOI: 10.1016/j.cgh.2008.05.022. View

Shen B . Acute and chronic pouchitis--pathogenesis, diagnosis and treatment. Nat Rev Gastroenterol Hepatol. 2012; 9(6):323-33. DOI: 10.1038/nrgastro.2012.58. View

Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers K, Brigidi P . Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology. 2003; 124(5):1202-9. DOI: 10.1016/s0016-5085(03)00171-9. View

Pronio A, Montesani C, Butteroni C, Vecchione S, Mumolo G, Vestri A . Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm Bowel Dis. 2008; 14(5):662-8. DOI: 10.1002/ibd.20369. View

Fazio V, Kiran R, Remzi F, Coffey J, Heneghan H, Kirat H . Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg. 2013; 257(4):679-85. DOI: 10.1097/SLA.0b013e31827d99a2. View

Schmidt C, Lazenby A, Hendrickson R, Sitzmann J . Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg. 1998; 227(5):654-62; discussion 663-5. PMC: 1191341. DOI: 10.1097/00000658-199805000-00006. View

Scarpa M, Grillo A, Faggian D, Ruffolo C, Bonello E, DInca R . Relationship between mucosa-associated microbiota and inflammatory parameters in the ileal pouch after restorative proctocolectomy for ulcerative colitis. Surgery. 2011; 150(1):56-67. DOI: 10.1016/j.surg.2011.02.009. View

Shen B . Pouchitis: what every gastroenterologist needs to know. Clin Gastroenterol Hepatol. 2013; 11(12):1538-49. DOI: 10.1016/j.cgh.2013.03.033. View

Tyler A, Milgrom R, Stempak J, Xu W, Brumell J, Muise A . The NOD2insC polymorphism is associated with worse outcome following ileal pouch-anal anastomosis for ulcerative colitis. Gut. 2012; 62(10):1433-9. DOI: 10.1136/gutjnl-2011-301957. View

10.

Duffy M, OMahony L, Coffey J, Collins J, Shanahan F, Redmond H . Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis Colon Rectum. 2002; 45(3):384-8. DOI: 10.1007/s10350-004-6187-z. View

11.

Shepherd N, Healey C, Warren B, Richman P, Thomson W, Wilkinson S . Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir. Gut. 1993; 34(1):101-5. PMC: 1374109. DOI: 10.1136/gut.34.1.101. View

12.

Sandborn W . Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology. 1994; 107(6):1856-60. DOI: 10.1016/0016-5085(94)90832-x. View

13.

Joelsson M, Andersson M, Bark T, Gullberg K, Hallgren T, Jiborn H . Allopurinol as prophylaxis against pouchitis following ileal pouch-anal anastomosis for ulcerative colitis. A randomized placebo-controlled double-blind study. Scand J Gastroenterol. 2001; 36(11):1179-84. DOI: 10.1080/00365520152584815. View

14.

Rafii F, Franklin W, Cerniglia C . Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora. Appl Environ Microbiol. 1990; 56(7):2146-51. PMC: 184574. DOI: 10.1128/aem.56.7.2146-2151.1990. View

15.

Shepherd N, Jass J, Duval I, MOSKOWITZ R, Nicholls R, MORSON B . Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol. 1987; 40(6):601-7. PMC: 1141046. DOI: 10.1136/jcp.40.6.601. View

16.

Langholz E, Munkholm P, Davidsen M, Binder V . Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 1994; 107(1):3-11. DOI: 10.1016/0016-5085(94)90054-x. View

17.

Ferrante M, Declerck S, De Hertogh G, Van Assche G, Geboes K, Rutgeerts P . Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis. 2007; 14(1):20-8. DOI: 10.1002/ibd.20278. View

18.

Peppercorn M, Goldman P . The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J Pharmacol Exp Ther. 1972; 181(3):555-62. View

19.

Targownik L, Singh H, Nugent Z, Bernstein C . The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort. Am J Gastroenterol. 2012; 107(8):1228-35. DOI: 10.1038/ajg.2012.127. View

20.

Belluzzi A, Serrani M, Roda G, Bianchi M, Castellani L, Grazia M . Pilot study: the use of sulfasalazine for the treatment of acute pouchitis. Aliment Pharmacol Ther. 2009; 31(2):228-32. DOI: 10.1111/j.1365-2036.2009.04163.x. View